# L_2020241EN.01001301.xml

| 27.7.2020 | EN | Official Journal of the European Union | L 241/13 |
| --- | --- | --- | --- |

27.7.2020

EN

Official Journal of the European Union

L 241/13

---

COMMISSION IMPLEMENTING REGULATION (EU) 2020/1093

of 24 July 2020

amending Implementing Regulation (EU) No 686/2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of active substances whose approval expires between 31 March 2025 and 27 December 2028

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (1), and in particular Article 19 thereof,

Whereas:

| (1) | Commission Implementing Regulation (EU) No 686/2012 (2) allocates the evaluation of active substances to a rapporteur Member State and to a co-rapporteur Member State for the purposes of the renewal procedure. Since the evaluation of active substances whose approval expires between 31 March 2025 and 27 December 2028 has not yet been allocated to a Member State or to a co-rapporteur Member State, it is appropriate to proceed to such allocation. |
| --- | --- |

(1)

Commission Implementing Regulation (EU) No 686/2012 (2) allocates the evaluation of active substances to a rapporteur Member State and to a co-rapporteur Member State for the purposes of the renewal procedure. Since the evaluation of active substances whose approval expires between 31 March 2025 and 27 December 2028 has not yet been allocated to a Member State or to a co-rapporteur Member State, it is appropriate to proceed to such allocation.

| (2) | That allocation should be made in such a way that a balance is achieved as regards the distribution of the responsibilities and the work between Member States. |
| --- | --- |

(2)

That allocation should be made in such a way that a balance is achieved as regards the distribution of the responsibilities and the work between Member States.

| (3) | Implementing Regulation (EU) No 686/2012 should therefore be amended accordingly. |
| --- | --- |

(3)

Implementing Regulation (EU) No 686/2012 should therefore be amended accordingly.

| (4) | The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed, |
| --- | --- |

(4)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

HAS ADOPTED THIS REGULATION:

Article 1

Implementing Regulation (EU) No 686/2012 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 24 July 2020.

For the Commission

The President

Ursula VON DER LEYEN

---

(1)  
  OJ L 309, 24.11.2009, p. 1.

1

(2)  Commission Implementing Regulation (EU) No 686/2012 of 26 July 2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of the active substances (OJ L 200, 27.7.2012, p. 5).

2

---

ANNEX

The Annex to Implementing Regulation (EU) No 686/2012 is amended as follows:

The following Part D is added:

‘PART D

Allocation of the evaluation of active substances whose approval expires between 31 March 2025 and 27 December 2028

| Active substance | Rapporteur Member State | Co-rapporteur Member State |
| --- | --- | --- |
| Alpha-cypermethrin | FR | AT |
| Bacillus amyloliquefaciens subsp. plantarum strain D747 | NL | SK |
| Bacillus amyloliquefaciens strain MBI 600 | NL | SK |
| Beauveria bassiana strain NPP111B005 | BE | RO |
| Beauveria bassiana strain 147 | BE | RO |
| Bentazone | PL | EL |
| Bordeaux mixture | IT | PL |
| Chromafenozide | CZ | MT |
| Copper hydroxide | IT | PL |
| Copper oxide | IT | PL |
| Copper oxychloride | IT | PL |
| Cyantraniliprole | ES | FI |
| Fenpicoxamid | SE | BG |
| Flupyradifurone | EL | PL |
| Gamma-cyhalothrin | DE | ES |
| Halauxifen-methyl | HU | SE |
| Isofetamid | PT | IE |
| Mandestrobin | SE | NO |
| Meptyldinocap | HR | DE |
| Methoxyfenozide | FR | HU |
| Metschnikowia fructicola strain NRRL Y-27328 | NL | HR |
| Oxathiapiprolin | NO | CZ |
| Pinoxaden | FI | BE |
| Propyzamide | DK | DE |
| Rescalure | IE | PT |
| Sulfoxaflor | AT | ES |
| Terpenoid blend QRD 460 | FR | DK |
| Tribasic copper sulphate | IT | PL’ |

Active substance

Rapporteur Member State

Co-rapporteur Member State

Alpha-cypermethrin

FR

AT

Bacillus amyloliquefaciens subsp. plantarum strain D747

NL

SK

Bacillus amyloliquefaciens strain MBI 600

NL

SK

Beauveria bassiana strain NPP111B005

BE

RO

Beauveria bassiana strain 147

BE

RO

Bentazone

PL

EL

Bordeaux mixture

IT

PL

Chromafenozide

CZ

MT

Copper hydroxide

IT

PL

Copper oxide

IT

PL

Copper oxychloride

IT

PL

Cyantraniliprole

ES

FI

Fenpicoxamid

SE

BG

Flupyradifurone

EL

PL

Gamma-cyhalothrin

DE

ES

Halauxifen-methyl

HU

SE

Isofetamid

PT

IE

Mandestrobin

SE

NO

Meptyldinocap

HR

DE

Methoxyfenozide

FR

HU

Metschnikowia fructicola strain NRRL Y-27328

NL

HR

Oxathiapiprolin

NO

CZ

Pinoxaden

FI

BE

Propyzamide

DK

DE

Rescalure

IE

PT

Sulfoxaflor

AT

ES

Terpenoid blend QRD 460

FR

DK

Tribasic copper sulphate

IT

PL’

---